QQ客服 官方微博 反馈留言

浏览/检索结果: 共10条，第1-10条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序作者升序作者降序提交时间升序提交时间降序题名升序题名降序 Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor 期刊论文 THORACIC CANCER, 2022 作者:  Wang, Wenxian;  Wang, Qian;  Xu, Chunwei;  Li, Ziming;  Song, Zhengbo 收藏  |  浏览/下载：42/0  |  提交时间：2022/12/23 checkpoint inhibitor pneumonitis  Chinese experts consensus  immune checkpoint inhibitor-related adverse effects   Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China 期刊论文 THORACIC CANCER, 2022 作者:  Xu, Chunwei;  Si, Lu;  Wang, Wenxian;  Li, Ziming;  Song, Zhengbo 收藏  |  浏览/下载：54/0  |  提交时间：2022/12/22 fusion  precision medicine  solid tumor  targeted therapy  tyrosine receptor kinase   A phase Ib/II study of AK112, a PD-1/VEGF bispecific antibody, as first- or second-line therapy for advanced non-small cell lung cancer (NSCLC). 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Zhou, Caicun;  Ren, Shengxiang;  Luo, Yongzhong;  Wang, Lei;  Xiong, Anwen 收藏  |  浏览/下载：27/0  |  提交时间：2022/12/23 Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial 期刊论文 LANCET ONCOLOGY, 2022, 卷号: 23 作者:  Zhou, Qing;  Chen, Ming;  Jiang, Ou;  Pan, Yi;  Hu, Desheng 收藏  |  浏览/下载：118/0  |  提交时间：2022/03/21 Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China 期刊论文 THORACIC CANCER, 2021 作者:  Shi, Yuequan;  Fang, Jian;  Zhou, Chengzhi;  Liu, Anwen;  Wang, Yan 收藏  |  浏览/下载：70/0  |  提交时间：2022/01/25 advanced lung cancer  immune checkpoint inhibitors  immune-related adverse events  real-world data   A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2017, 卷号: 12, 期号: 1 作者:  Zhao, Yizhuo;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua;  Wang, Zhehai 收藏  |  浏览/下载：14/0  |  提交时间：2019/12/04 NSCLC  Anlotinib  multi-targeted tyrosine kinase inhibitor   A randomized phase III trial of capecitabine with or without irinotecan driven by UGT1A1 in neoadjuvant chemoradiation of locally advanced rectal cancer (CinClare). 会议论文 作者:  Zhu, Ji;  Sun, Xinchen;  Zhang, Tao;  Liu, Anwen;  Zhu, Yuan 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2017, 卷号: 12, 页码: S886-S887 作者:  Han, Baohui;  Li, Kai;  Zhao, Yizhuo;  Wang, Qiming;  Zhang, Li 收藏  |  浏览/下载：9/0  |  提交时间：2019/11/26 NSCLC  multi-targeted tyrosine kinase inhibitor  Anlotinib   A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) 期刊论文 2017, 卷号: 12, 期号: 1, 页码: S886-S887 作者:  Han, Baohui;  Li, Kai;  Zhao, Yizhuo;  Wang, Qiming;  Zhang, Li 收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03 NSCLC  Anlotinib  multi-targeted tyrosine kinase inhibitor   The effect of folic acid on ovine fetuses in utero during late gestation 期刊论文 DRUG AND CHEMICAL TOXICOLOGY, 2012, 卷号: 35, 期号: 2 作者:  Mao, Caiping;  Liu, Yujuan;  Jiang, Shan;  Zhou, Anwen;  Zhang, Peiwen 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 Folic acid  gestation  ovine fetus in utero  cardiac  hepatic  renal functions